PSA
38
-8
NWL
50
-4
LMT
20
-7
YUM
36
-4
DUK
39
-8
DG
10
-2
WEC
31
-5
HRB
47
-4
VLO
23
-6
UNH
38
2
XRX
44
-4
ACN
49
7
HD
38
-8
TJX
51
-7
UAL
63
-9
HPE
42
-11
K
45
-5
NOV
44
-3
SE
55
-10
CHRW
53
-4
PSA
38
-8
NWL
50
-4
LMT
20
-7
YUM
36
-4
DUK
39
-8
DG
10
-2
WEC
31
-5
HRB
47
-4
VLO
23
-6
UNH
38
2
XRX
44
-4
ACN
49
7
HD
38
-8
TJX
51
-7
UAL
63
-9
HPE
42
-11
K
45
-5
NOV
44
-3
SE
55
-10
CHRW
53
-4
Financhill
Back

Viking Therapeutics 10K Form

Sell
28

VKTX
Viking Therapeutics

Last Price:
38.24
Seasonality Move:
40.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VKTX News And Ratings

See the #1 stock for the next 7 days that we like better than VKTX

VKTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-21.96M
Price / Cash Flow: 0
Annual Sales: $8.18
Price / Book: 5.71

Profitability

EPS (TTM): -0.93000
Net Income (TTM): $-99.15M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Viking Therapeutics Earnings Forecast

Key Viking Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Viking Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VKTX
CUSIP: 92686J
Website: vikingtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VKTX Technical Analysis vs Fundamental Analysis

Sell
28
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy or a Sell?